Sushil Patel
Chief Executive Officer bij REPLIMUNE GROUP, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Sushil Patel is currently the Chief Executive Officer & Director at Replimune Group, Inc. since 2024 and an Independent Director at Revolution Medicines, Inc. since 2022.
Previously, he worked at Genentech, Inc. from 2002 to 2021, where he held the position of Vice President-Franchise & Head-Oncology from 2008 to 2021.
Dr. Patel completed his graduate degree at Imperial College London in 1993, obtained a doctorate degree from the University of London in 1999, and received his undergraduate degree from the University of Warwick in 1992.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
REPLIMUNE GROUP, INC.
0.38% | 01-04-2024 | 232 208 ( 0.38% ) | 2 M $ | 31-03-2024 |
| 10-04-2024 | 15 700 ( 0.01% ) | 506 011 $ | 31-03-2024 |
Actieve functies van Sushil Patel
| Bedrijven | Functie | Begin |
|---|---|---|
| REPLIMUNE GROUP, INC. | Chief Executive Officer | 01-04-2024 |
| REVOLUTION MEDICINES, INC. | Director/Board Member | 16-06-2022 |
Eerdere bekende functies van Sushil Patel
| Bedrijven | Functie | Einde |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-05-2021 |
Opleiding van Sushil Patel
| Imperial College London | Graduate Degree |
| University of London | Doctorate Degree |
| University of Warwick | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| REVOLUTION MEDICINES, INC. | Health Technology |
| REPLIMUNE GROUP, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
